Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib

Chul Cho Byoung, Chong Kun Im, Moo Suk Park, Kyu Kim Se, Joon Chang, Pil Park Jong, Jin Choi Hye, Jin Kim Yu, Sang Joon Shin, Hyuk Sohn Joo, Hoguen Kim, Hang Kim Joo

Research output: Contribution to journalArticlepeer-review

146 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II study of erlotinib in advanced non-small-cell lung cancer after failure of gefitinib'. Together they form a unique fingerprint.

Medicine & Life Sciences